India to Algeria: Budesonide Export Trade Route
India has recorded 121 verified shipments of Budesonide exported to Algeria, representing a combined trade value of $13.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $108.8K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 94% of total export value with 113 shipments worth $12.4M USD. On the buying side, BIOPHARM DISTRIBUTION SPA is the largest importer in Algeria with $7.5M USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , POLLOMI PHARMACEUTICAL PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Algeria Budesonide corridor is one of India's established pharmaceutical export routes, with 121 shipments documented worth a combined $13.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's budesonide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $108.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 26.1%, placing it at rank #8 among India's top budesonide export destinations globally.
On the import side, key buyers of Indian budesonide in Algeria include BIOPHARM DISTRIBUTION SPA, BIOPHARM DISTRIBUTION SPA,, TO THE ORDER OF CITIBANK N A ALGERI and 3 others. BIOPHARM DISTRIBUTION SPA is the single largest importer with 56 shipments valued at $7.5M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portJNPT
Market Position
- Global rank#8
- Annual growth+26.1%
- Demand growth+21.9%
- Regulatory ease65/100
Top 10 Indian Budesonide Exporters to Algeria
Showing top 10 of 3 Indian suppliers exporting Budesonide to Algeria, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $109.4K per shipment | 113 | $12.4M | 93.9% |
| 2 | CIPLA LIMITED Avg $190.6K per shipment | 4 | $762.4K | 5.8% |
| 3 | POLLOMI PHARMACEUTICAL PRIVATE LIMITED Avg $9.3K per shipment | 4 | $37.1K | 0.3% |
This table shows the top 10 of 3 Indian companies exporting budesonide to Algeria, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , POLLOMI PHARMACEUTICAL PRIVATE LIMITED. CIPLA LIMITED is the dominant supplier with 113 shipments worth $12.4M USD, giving it a 94% market share.
Top 10 Budesonide Importers in Algeria
Showing top 10 of 6 known buyers in Algeria receiving Budesonide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian budesonide in Algeria include BIOPHARM DISTRIBUTION SPA, BIOPHARM DISTRIBUTION SPA,, TO THE ORDER OF CITIBANK N A ALGERI, BIOPHARM DISTRIBUTION SPA , TO CITIBANK N A, among 6 total buyers. The largest importer is BIOPHARM DISTRIBUTION SPA, accounting for $7.5M USD across 56 shipments — representing 57% of all budesonide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOPHARM DISTRIBUTION SPA | 56 | $7.5M | 57.0% |
| 2 | BIOPHARM DISTRIBUTION SPA, | 38 | $2.7M | 20.2% |
| 3 | TO THE ORDER OF CITIBANK N A ALGERI | 17 | $2.2M | 16.4% |
| 4 | BIOPHARM DISTRIBUTION SPA | 4 | $762.4K | 5.8% |
| 5 | TO CITIBANK N A | 2 | $42.2K | 0.3% |
| 6 | SARL BIOLOGIE VITAMINE D'ALGERIE | 4 | $37.1K | 0.3% |
Top 10 Budesonide Formulations Imported by Algeria
Showing top 10 of 31 product formulations shipped on the India to Algeria Budesonide route, ranked by trade value
Algeria imports a wide range of budesonide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BUDECORT 200 INHALER WITH DOSE IDICATOR (BUDESONIDE 200MCG) 1 X 200 MD — accounts for $2.6M USD across 21 shipments. There are 31 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BUDECORT 200 INHALER WITH DOSE IDICATOR (BUDESONIDE 200MCG) 1 X 200 MD | 21 | $2.6M | 19.8% |
| 2 | BUDECORT 200 INHALER WITH DOSE IDICATOR BUDESONIDE 200 MCG | 12 | $1.5M | 11.2% |
| 3 | BUDECORT 200 INHALER WITH DOSE IDICATORBUDESONIDE 200 MCG. | 8 | $1.1M | 8.3% |
| 4 | FORACORT HFA 200 INHALER + (FORMOTEROL FUMARATE 6MCG + BUDESONIDE 200MCG) (PAC SIZE:1X120 MD) | 3 | $792.4K | 6.0% |
| 5 | BUDECORT 200 INHALER WITH DOSE IDICATOR (BUDESONIDE 200MCG) | 4 | $762.4K | 5.8% |
| 6 | BUDECORT 200 INHALER WITH DOSE INDICATOR BUDESONIDE 200 MCG | 5 | $680.8K | 5.2% |
| 7 | BUDECORT 200 INHALER WITH DOSE IDICATOR(BUDESONIDE 200 MCG).NOS | 12 | $568.4K | 4.3% |
| 8 | BUDECORT 200 INHALER WITH DOSE INDICATOR(BUDESONIDE 200 MCG)NOS | 12 | $567.0K | 4.3% |
| 9 | BUDECORT 200 INHALER WITH DOSE IDICATOR BUDESONIDE 200MCG 1 X 200 MD | 4 | $503.0K | 3.8% |
| 10 | BUDECORT 200 INHALER WITH DOSE IDICATOR(BUDESONIDE 200MCG) (1 X 200 MD) | 4 | $483.5K | 3.7% |
Showing top 10 of 31 Budesonide formulations imported by Algeria on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
JNPT handles the highest volume with 25 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's budesonide exports to Algeria are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 113 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Algeria benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , POLLOMI PHARMACEUTICAL PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $108.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as budecort 200 inhaler with dose idicator budesonide 200 mcg and budecort 200 inhaler with dose idicatorbudesonide 200 mcg., suggesting that buyers in Algeria tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOPHARM DISTRIBUTION SPA is the largest importer with 56 shipments worth $7.5M USD — representing 57% of all budesonide imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $13.2M
- Avg. Shipment
- $108.8K
- Suppliers
- 3
- Buyers
- 6
- Transit (Sea)
- ~29 days
- Annual Growth
- +26.1%
Related Analysis
Other Budesonide Routes
Unlock the Full India to Algeria Budesonide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 121 shipments on this route.
Frequently Asked Questions — India to Algeria Budesonide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Budesonide to Algeria?
The leading Indian exporters of Budesonide to Algeria are CIPLA LIMITED, CIPLA LIMITED , POLLOMI PHARMACEUTICAL PRIVATE LIMITED. CIPLA LIMITED holds the largest market share at approximately 94% of total trade value on this route.
Q What is the total value of Budesonide exports from India to Algeria?
India exports Budesonide to Algeria worth approximately $13.2M USD across 121 recorded shipments. The average value per shipment is $108.8K USD.
Q Which ports does India use to ship Budesonide to Algeria?
The most active port of origin is JNPT with 25 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Algeria for Budesonide?
The average transit time for Budesonide shipments from India to Algeria is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Algeria Budesonide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.1% with demand growth tracking at 21.9%. The route is ranked #8 among India's top Budesonide export destinations globally.
Q How many suppliers are active on the India to Algeria Budesonide route?
There are currently 3 active Indian suppliers exporting Budesonide to Algeria. The market is moderately concentrated with CIPLA LIMITED accounting for 94% of total shipment value.
Q Who are the main importers of Budesonide from India in Algeria?
The leading importers of Indian Budesonide in Algeria include BIOPHARM DISTRIBUTION SPA, BIOPHARM DISTRIBUTION SPA,, TO THE ORDER OF CITIBANK N A ALGERI, BIOPHARM DISTRIBUTION SPA , TO CITIBANK N A. BIOPHARM DISTRIBUTION SPA is the largest buyer with 56 shipments worth $7.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Algeria export trade corridor identified from Indian Customs (DGFT) records for Budesonide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 6 importers in Algeria matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 121 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
121 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists